drugset / Trial / NCT05166343
POHCA Resuscitation: Evaluation of IM Epinephrine
Phase 2/3
Recruiting
284 enrolled
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
RandomizedParallel-groupOpen-labelSupportive care
Summary
This is a pragmatic, two-arm, open-label, prospective stepped-wedge cluster quasi randomized control trial (SW-CRCT) looking to evaluate early intramuscular (IM) epinephrine in the management of pediatric out-of-hospital cardiac arrest (POHCA).
Timeline
- Start
- 2024-01-08
- Primary completion
- 2028-01
- Completion
- 2029-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epinephrine | Other / unclassified | 0.3 mg | Intramuscular |
| Subject | Epinephrine | Other / unclassified | 0.5 mg | Intramuscular |
| Subject | Epinephrine | Other / unclassified | 1 mg | Intramuscular |
| Subject | Epinephrine | Other / unclassified | 2 mg | Intramuscular |
| Subject | Epinephrine | Other / unclassified | 3 mg | Intramuscular |